Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

A man developed alopecia areata after starting cancer treatment with vandetanib.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Adding vitamin D to metformin lowers blood sugar more than metformin alone in type 2 diabetes.

The smart bandage improved healing in diabetic wounds better than standard treatments.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Metformin/dopamine-derived carbon dots help heal bacteria-infected wounds faster.

Proper skin care and dermocosmetics improve skin issues in diabetes patients.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

JAK inhibitors may help improve symptoms in adults with APECED.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.